Steglatro “Now Approved” Patient Website

Brand: Steglatro (ertugliflozin), Tablets
Parent Company: Merck
Drug Type: Prescription
Drug Category: Endocrinology
Campaign: now-approved
Targeting: Patients, Caregivers
Patient Website: https://www.steglatro.com/
HCP Website: https://www.merckconnect.com/steglatro/overview.html